STRS Ohio’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-8,300
| Closed | -$1.06M | – | 2202 |
|
|
2025
Q2 | $1.06M | Buy |
8,300
+1,600
| +24% | +$166K | ﹤0.01% | 898 |
|
|
2025
Q1 | $593K | Buy |
6,700
+200
| +3% | +$19.5K | ﹤0.01% | 1083 |
|
|
2024
Q4 | $567K | Buy |
6,500
+300
| +5% | +$27.5K | ﹤0.01% | 1114 |
|
|
2024
Q3 | $574K | Sell |
6,200
-1,300
| -17% | -$129K | ﹤0.01% | 1171 |
|
|
2024
Q2 | $808K | Buy |
7,500
+1,800
| +32% | +$180K | ﹤0.01% | 957 |
|
|
2024
Q1 | $540K | Sell |
5,700
-1,100
| -16% | -$94.3K | ﹤0.01% | 1205 |
|
|
2023
Q4 | $627K | Buy |
6,800
+3,300
| +94% | +$214K | ﹤0.01% | 1136 |
|
|
2023
Q3 | $175K | Sell |
3,500
-1,400
| -29% | -$74.8K | ﹤0.01% | 1594 |
|
|
2023
Q2 | $309K | Buy |
4,900
+2,700
| +123% | +$147K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $98K | Buy |
2,200
+300
| +16% | +$13.5K | ﹤0.01% | 1718 |
|
|
2022
Q4 | $83K | Sell |
1,900
-4,000
| -68% | -$192K | ﹤0.01% | 1746 |
|
|
2022
Q3 | $388K | Buy |
5,900
+1,900
| +48% | +$122K | ﹤0.01% | 1417 |
|
|
2022
Q2 | $202K | Sell |
4,000
-2,900
| -42% | -$170K | ﹤0.01% | 1607 |
|
|
2022
Q1 | $440K | Hold |
6,900
| – | – | ﹤0.01% | 1491 |
|
|
2021
Q4 | $739K | Sell |
6,900
-700
| -9% | -$73.2K | ﹤0.01% | 1326 |
|
|
2021
Q3 | $781K | Sell |
7,600
-800
| -10% | -$74.5K | ﹤0.01% | 1278 |
|
|
2021
Q2 | $738K | Buy |
8,400
+800
| +11% | +$73.3K | ﹤0.01% | 1404 |
|
|
2021
Q1 | $738K | Sell |
7,600
-7,200
| -49% | -$719K | ﹤0.01% | 1386 |
|
|
2020
Q4 | $1.66M | Buy |
14,800
+7,600
| +106% | +$801K | 0.01% | 785 |
|
|
2020
Q3 | $667K | Sell |
7,200
-1,000
| -12% | -$77K | ﹤0.01% | 1164 |
|
|
2020
Q2 | $639K | Buy |
8,200
+600
| +8% | +$40.6K | ﹤0.01% | 1125 |
|
|
2020
Q1 | $444K | Buy |
7,600
+2,000
| +36% | +$129K | ﹤0.01% | 1224 |
|
|
2019
Q4 | $448K | Sell |
5,600
-1,800
| -24% | -$135K | ﹤0.01% | 1480 |
|
|
2019
Q3 | $543K | Hold |
7,400
| – | – | ﹤0.01% | 1225 |
|
|
2019
Q2 | $698K | Buy |
7,400
+2,800
| +61% | +$231K | ﹤0.01% | 1013 |
|
|
2019
Q1 | $368K | Buy |
4,600
+1,500
| +48% | +$111K | ﹤0.01% | 1459 |
|
|
2018
Q4 | $167K | Sell |
3,100
-300
| -9% | -$18.2K | ﹤0.01% | 1672 |
|
|
2018
Q3 | $265K | Sell |
3,400
-3,100
| -48% | -$215K | ﹤0.01% | 1646 |
|
|
2018
Q2 | $412K | Buy |
6,500
+600
| +10% | +$47.7K | ﹤0.01% | 1465 |
|
|
2018
Q1 | $541K | Buy |
5,900
+2,000
| +51% | +$172K | ﹤0.01% | 1289 |
|
|
2017
Q4 | $294K | Buy |
3,900
+1,600
| +70% | +$113K | ﹤0.01% | 1437 |
|
|
2017
Q3 | $160K | Sell |
2,300
-20,600
| -90% | -$1.1M | ﹤0.01% | 1565 |
|
|
2017
Q2 | $1.16M | Buy |
22,900
+2,600
| +13% | +$110K | 0.01% | 756 |
|
|
2017
Q1 | $811K | Sell |
20,300
-7,400
| -27% | -$265K | ﹤0.01% | 950 |
|
|
2016
Q4 | $776K | Buy |
27,700
+1,500
| +6% | +$45.2K | ﹤0.01% | 1004 |
|
|
2016
Q3 | $778K | Buy |
+26,200
| New | +$651K | ﹤0.01% | 953 |
|
|
2015
Q3 | – | Sell |
-3,000
| Closed | -$83K | – | 1886 |
|
|
2015
Q2 | $79K | Buy |
+3,000
| New | +$85.7K | ﹤0.01% | 1710 |
|
Other funds holding BPMC
IA
HNB
STRS Ohio's BPMC Position: Q3 2025 in Review
STRS Ohio sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 8,300 shares — an estimated $1.06M sold.
STRS Ohio first reported a position in BPMC in Q2 2015 and held it in 37 quarters. The position peaked at $1.66M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- STRS Ohio reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- STRS Ohio sold 8,300 Blueprint Medicines shares in Q3 2025, an estimated $1.06M.
- STRS Ohio first reported a position in Blueprint Medicines in Q2 2015 and held it in 37 quarters.
- STRS Ohio's Blueprint Medicines position peaked at $1.66M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.